tert-butylhydroperoxide has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, DA; Johnson, JA; Williamson, TP | 1 |
1 other study(ies) available for tert-butylhydroperoxide and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antigens, Neoplasm; Antioxidants; Astrocytes; Binding Sites; Biomarkers, Tumor; Cells, Cultured; Cytoprotection; Cytoskeletal Proteins; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Genetic Therapy; Kelch-Like ECH-Associated Protein 1; Lectins, C-Type; Mice; Mice, Transgenic; MPTP Poisoning; NF-E2-Related Factor 2; Oxidants; Oxidative Stress; Pancreatitis-Associated Proteins; Response Elements; RNA Interference; RNA, Small Interfering; tert-Butylhydroperoxide; Time Factors; Transfection | 2012 |